Mark Rimer Net Worth

Mark Rimer biography

Mark Rimer is Director of the Company. Mr. Rimer, has been a partner at Kuzari Group, a boutique private investment group with a broad mandate to invest in full or partial buy-outs, growth capital and venture capital across a broad range of industries, since September 2009. Mr. Rimer serves on the board of directors of several companies, including Precipio, and is actively involved in business development roles at numerous portfolio companies. Prior to joining Kuzari, Mr. Rimer worked for a London-based private equity group, RP Capital Group, managing a number of investments across several emerging markets. Mr. Rimer is a Chartered Accountant, earned his undergraduate degree in Politics and Economics from Bristol University, and his MBA from the NY Stern School of Business.

How old is Mark Rimer?

Mark Rimer is 36, he's been the Director of Precipio Inc since 2017. There are 6 older and 2 younger executives at Precipio Inc. The oldest executive at Precipio Inc is Richard Sandberg, 77, who is the Director.

What's Mark Rimer's mailing address?

Mark's mailing address filed with the SEC is C/O PRECIPIO, INC., 4 SCIENCE PARK, NEW HAVEN, CT, 06511.

Insiders trading at Precipio Inc

Over the last 7 years, insiders at Precipio Inc have traded over $449,545 worth of Precipio Inc stock and bought 88,796 units worth $87,860 . The most active insiders traders include Randal J Kirk, Ronald Asbury Andrews a Richard A Sandberg. On average, Precipio Inc executives and independent directors trade stock every 54 days with the average trade being worth of $44,781. The most recent stock trade was executed by Richard A Sandberg on 20 January 2023, trading 20,000 units of PRPO stock currently worth $15,600.

What does Precipio Inc do?

precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine. our goal is to assist oncologists in providing the best care for their patients. at the intersection of academia, cancer research, and diagnostics, we connect physicians with world-renown pathologists at the yale school of medicine. at precipio, our customers and their patients benefit from the most accurate, expert diagnosis. we provide our customers exclusive access to some of the most innovative tests in the field of molecular diagnostics, developed through cutting edge research, and the ongoing pursuit and refinement of the science of personalized medicine.

Precipio Inc executives and stock owners

Precipio Inc executives and other stock owners filed with the SEC include:

• Ilan Danieli,
  Founder, Pres, CEO & Director
• Carl R. Iberger,
  CFO & Sec.
• Ayman Mohamed M.D.,
  Sr. VP of R&D and Laboratory Operations
• Ahmed Zaki Sabet,
  Chief Operating Officer
• Kathleen LaPorte,
  Independent Director
• Jeffrey Cossman,
  Independent Director
• Richard Sandberg,
  Director
• Mark Rimer,
  Director
• David Cohen,
  Director
• Ori Karev,
  Chief Strategy Officer
• Douglas Sites,
  Vice President - Sales
• Carl Iberger,
  Chief Financial Officer
• Ilan Danieli,
  President, Chief Executive Officer, Director
• Douglas Fisher,
  Interim Chairman of the Board
• Miri Chiko-Radomski,
  Gen. Counsel
• Ronald Asbury Andrews,
  Director
• Randal J Kirk,
  10% owner
• Robert Patzig,
  Director
• Samuel D Riccitelli,
  Director
• Michael A Luther,
  Director
• Ahmed Zaki Sabet,
  Chief Operating Officer
• Christina Rizopoulos Valauri,
  Director
• Matthew Gage,
  Chief Financial Officer